CVS Health Corp (NYSE: CVS) on November 20, 2023, started off the session at the price of $68.40, plunging -0.80% from the previous trading day. During the day, the shares moved up to $68.79 and dropped to $67.79 before settling in for the closing price of $68.81. Within the past 52 weeks, CVS’s price has moved between $64.41 and $104.83.
During the last 5-year period, the sales growth of Healthcare Sector giant was 12.22%. The company achieved an average annual earnings per share of -1.19%. With a float of $1.28 billion, this company’s outstanding shares have now reached $1.30 billion.
Let’s determine the extent of company efficiency that accounts for 300000 employees. In terms of profitability, gross margin is +16.92, operating margin of +5.08, and the pretax margin is +1.74.
CVS Health Corp (CVS) Insider Activity
Observing investor behavior towards Healthcare Plans industry stocks is more important than anything else. The insider ownership of CVS Health Corp is 0.18%, while institutional ownership is 79.30%. The most recent insider transaction that took place on Nov 03, was worth 140,930. In this transaction Director of this company bought 2,000 shares at a rate of $70.47, taking the stock ownership to the 20,630 shares. Before that another transaction happened on Aug 03, when Company’s SVP, Cont & Chief Acct Officer sold 25,759 for $74.92, making the entire transaction worth $1,930,004. This insider now owns 4,698 shares in total.
CVS Health Corp (CVS) Earnings and Forecasts
As on 9/29/2023, Multinational firm has announced its last quarter scores, in which it reported $2.02 earnings per share (EPS) for the period topping the consensus outlook (set at $1.96) by $0.06. This company achieved a net margin of +1.29 while generating a return on equity of 5.68. Wall Street market experts anticipate that the next fiscal year will bring earnings of 1.86 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around -1.19% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 3.93% during the next five years compared to -13.40% drop over the previous five years of trading.
CVS Health Corp (NYSE: CVS) Trading Performance Indicators
CVS Health Corp (CVS) is currently performing well based on its current performance indicators. A quick ratio of 0.64 was reported for the most recent quarter. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.25. Likewise, its price to free cash flow for the trailing twelve months is 7.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 6.63, a number that is poised to hit 1.97 in the next quarter and is forecasted to reach 8.51 in one year’s time.
Technical Analysis of CVS Health Corp (CVS)
Looking closely at CVS Health Corp (NYSE: CVS), its last 5-days average volume was 7.09 million, which is a drop from its year-to-date volume of 8.7 million. As of the previous 9 days, the stock’s Stochastic %D was 46.66%. Additionally, its Average True Range was 1.53.
During the past 100 days, CVS Health Corp’s (CVS) raw stochastic average was set at 29.68%, which indicates a significant decrease from 55.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.47% in the past 14 days, which was lower than the 24.67% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $69.86, while its 200-day Moving Average is $72.68. However, in the short run, CVS Health Corp’s stock first resistance to watch stands at $68.77. Second resistance stands at $69.28. The third major resistance level sits at $69.77. If the price goes on to break the first support level at $67.77, it is likely to go to the next support level at $67.28. Should the price break the second support level, the third support level stands at $66.77.
CVS Health Corp (NYSE: CVS) Key Stats
Market capitalization of the company is 87.84 billion based on 1,286,897K outstanding shares. Right now, sales total 322,467 M and income totals 4,149 M. The company made 89,764 M in profit during its latest quarter, and 2,261 M in sales during its previous quarter.